Huma

The rounds this investor is named on, who it invests beside, and where it shows up.

Named on one round in the feed.

Since 2026-09-23

ROUNDS

joined, none as lead

ROUNDS · USD

$13.7M

across 1 round

LATEST ROUND

Series A · $13.7M · 2026-09-23

CO-INVESTORS

named beside it

Rounds

[ 1 ]

The rounds this investor is named on, who it invests beside, and where it shows up.

Huma: 1 round · Fireround

Company	Round	Amount	Announced	Role
ViferaXS A clinical-stage biotechnology company developing peptide-based cancer immunotherapy for hematologic malignancies and solid tumors	Series A Published on thinner evidence, 1 source	$13.7M	2026-09-23	[ PART ]